20952 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Growth factors; Growth regulators Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
ADJUSTABLE GENE THERAPY
#2BDNF GENE THERAPY
#3PAINLESS NGF FOR FRACTURE REPAIR
#4USE OF ENCAPSULATED CELL THERAPY FOR TREATMENT OF OPHTHALMIC DISORDERS
#5INTRANASAL ADMINISTRATION OF BDNF FOR THE TREATMENT OF SENSORINEURAL HEARING LOSS
#6COMBINATION FOR USE IN OPHTHALMOLOGY
#7COMPOSITION FOR PREVENTING OR TREATING HERNIATED INTERVERTEBRAL DISC OR PAIN CAUSED THEREBY, COMPRISING HYDROGEL PATCH
#8METHODS AND DEVICES FOR PROMOTING NERVE GROWTH AND REGENERATION
#9MEDICAL PATCH FOR CONTROLLED DELIVERY OF WOUND HEALING FACTORS AND THERAPIES
#10TISSUE REGENERATIVE MULTI-DRUG COCKTAIL AND APPARATUS FOR DELIVERY THEREOF
#11ANTI-SOD1 NANOBODIES
#12METHODS FOR PROMOTING WOUND HEALING AND HAIR GROWTH COMPRISING GDNF ADMINISTRATION
#13BICYCLIC COMPOUNDS AND METHODS FOR THEIR USE IN TREATING PITT HOPKINS SYNDROME
#14METHODS FOR MAKING HUMAN GROWTH FACTOR CONCENTRATE AND COMPOSITIONS AND USES THEREOF
#15USE OF CEREBRAL DOPAMINE NEUROTROPHIC FACTOR FOR AMELIORATING PNEUMONIA
#16COATINGS FOR BIOLOGICAL INTERFACE ON IMPLANTS
#17COMPOSITION FOR PREVENTING OR TREATING DEGENERATIVE BRAIN DISEASES
#18HISTATIN COMBINATIONS AND METHODS FOR TREATING OR INHIBITING CELL LOSS
#19METHODS AND PHARMACEUTICAL COMPOSITIONS FOR MODULATING TEAR FILM COMPOSITION TO TREAT CORNEAL DEFECTS
#20GENE THERAPY FOR THE TREATMENT OF COGNITIVE DISORDERS
#21METHODS AND COMPOSITIONS FOR THE TREATMENT OF PARKINSON'S DISEASE
#22Supraparticles
#23SYNTHETIC PLATELETS
#24METHODS FOR PROMOTING WOUND HEALING AND HAIR GROWTH COMPRISING GDNF ADMINISTRATION
#25ADHESIVE CELL TISSUE GELS
#26DRUG-DELIVERING NERVE WRAP
#27BIOACTIVE GRANULAR HYDROGEL SCAFFOLDS AND USE THEREOF
#28COMPOSITIONS AND METHODS FOR MODULATING NEURONAL EXCITABILITY AND MOTOR BEHAVIOR
#29PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF INFLAMMATORY DISEASE OR PAIN, COMPRISING MESENCHYMAL STEM CELLS EXPRESSING PTX-3, TIMP1 AND BDNF AS ACTIVE INGREDIENT
#30TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS USING PKC ACTIVATORS
#31USE OF ENCAPSULATED CELL THERAPY FOR TREATMENT OF OPHTHALMIC DISORDERS
#32AADC/GDNF POLYNUCLEOTIDE, AND USE THEREOF IN TREATING PARKINSON'S DISEASE
#33NEUROPROTECTIVE COMPOSITIONS AND USE THEREOF
#34FUNCTIONALIZED BIOLOGICAL MEMBRANES WITH MODIFYING PROTEIN MOLECULES, AND METHODS OF MAKING AND USES THEREOF
#35COMPOSITIONS AND ARTICLES COMPRISING AN ADNF POLYPEPTIDE
#36USE OF ADNF POLYPEPTIDES IN THERAPY
#37RECOMBINANT PROTEIN OF NERVE GROWTH FACTOR MUTANT AND USE THEREOF
#38Methods and Compositions for Treating Conditions Involving the Eye
#39NGF ISOFORM FOR USE IN THE TREATMENT OF OCULAR PATHOLOGIES
#40PHARMACEUTICAL COMPOSITION AND KIT COMPRISING AN IMMUNOMODULATORY SUBSTANCE FOR TREATING DISEASES
#41GPI ANCHORED PROTEINS AND EXTRACELLULAR VESICLES COMPRISING THEM
#42Systems and Methods for Angiogenic Treatment in Wound Healing
#43ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF RETT SYNDROME
#44METHODS AND COMPOSITIONS FOR INDUCING DIFFERENTIATION OF HUMAN BROWN ADIPOCYTE PROGENITORS
#45METHOD FOR MANUFACTURING A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SPINAL CORD INJURY
#46IMMUNOREGULATORY MOLECULES AND USES THEREFOR
#47COMBINATION THERAPY FOR THE TREATMENT OF ENTERIC NEUROPATHIES
#48AURIS FORMULATIONS FOR TREATING OTIC DISEASES AND CONDITIONS
#49Methods and Compositions for Treating Conditions Involving the Eye
#50DELIVERY SYSTEM AND METHOD FOR USING SAME
#51Gene therapy DNA vector based on gene therapy DNA vector VTvaf17 carrying the therapeutic gene selected from the group of BDNF, VEGFA, BFGF, NGF, GDNF, NT3, CNTF, and IGF1 genes for increasing the expression level of these therapeutic genes, method of its production and use, Escherichia coli strain SCS110-AF/VTvaf17-BDNF, or Escherichia coli strain SCS110-AF/VTvaf17-VEGFA, or Escherichia coli strain SCS110-AF/VTvaf17-BFGF, or Escherichia coli strain SCS110-AF/VTvaf17-NGF, or Escherichia coli str
#52DYNAMIC BIOACTIVE SCAFFOLDS AND THERAPEUTIC USES THEREOF AFTER CNS INJURY
#53USE OF ENCAPSULATED CELL THERAPY FOR TREATMENT OF OPHTHALMIC DISORDERS
#54PAINLESS NGF FOR FRACTURE REPAIR
#55NEURO-MESENCHYME UNITS CONTROL ILC2 AND OBESITY VIA A BRAIN-ADIPOSE CIRCUIT
#56USE OF IMMUNE MODULATORS TO IMPROVE NERVE REGENERATION
#57PHARMACEUTICAL COMPOSITION AND KIT COMPRISING AN IMMUNOMODULATORY SUBSTANCE FOR TREATING DISEASES
#58Fusion Protein Containing BDNF
#59PHARMACEUTICAL COMPOSITION AND KIT COMPRISING AN IMMUNOMODULATORY SUBSTANCE FOR TREATING DISEASES
#60AAV VIRION ENCODING NEUROTROPHIC FACTOR AND USES THEREOF
#61NERVE GROWTH FACTOR FUSION PROTEIN, PREPARATION METHOD AND USE THEREOF
#62CO-THERAPY WITH VECTOR AND NICOTINIC AGONIST
#63TREATMENT OF NEUROPATHIC CORNEAL PAIN WITH NGF
#64METHODS FOR PROMOTING WOUND HEALING AND HAIR GROWTH
#65COMBINED TREATMENT OF BRAIN INJURY
#66NERVE GROWTH FACTOR FUSION PROTEIN, PREPARATION METHOD AND USE THEREOF
#67NGF ISOFORM FOR USE IN THE TREATMENT OF OCULAR PATHOLOGIES
#68BDNF OTIC FORMULATIONS AND USE THEREOF
#69Synthetic platelets
#70Methods of treatment and prevention using 4-deoxy-L-erythro-5-hexoseulose uronic acid
#71PHARMACEUTICAL PACKAGES COMPRISING POLYPROPYLENE CONTAINERS AND NGF AQUEOUS FORMULATIONS PACKAGED THEREIN
#72COMPOSITION FOR PREVENTING OR TREATING NEUROPSYCHOLOGIC DISEASE, COMPRISING MANF
#73PEPTIDE FOR THERAPEUTIC APPLICATIONS IN THE DERMATOLOGICAL FIELD
#74NOVEL ENGINEERED CAPSID SEROTYPE OF RECOMBINANT ADENO-ASSOCIATED VIRAL VECTOR WITH ENHANCED TRANSDUCTION EFFICIENCY AND WIDESPREAD DISTRIBUTION IN THE BRAIN
#75Use of Cell-Free Fat Extract for Treating Osteoporosis
#76BICYCLIC COMPOUNDS AND METHODS FOR THEIR USE IN TREATING PITT HOPKINS SYNDROME
#77EFFECTS OF CELL-FREE FAT LIQUID EXTRACT ON MACROPHAGE POLARIZATION MODULATION AND DISEASE TREATMENT
#78COMPOSITIONS HAVING NEUROREGENERATIVE APPLICATIONS
#79NERVE GROWTH FACTOR MUTANT
#80NEW DRUG DELIVERY SYSTEM FOR OPHTALMIC USE
#81GROWTH FACTOR OTIC FORMULATIONS
#82Improved Supraparticles
#83GROWTH FACTOR FORMULATION FOR CONDITION ASSOCIATED WITH OTIC EVENT
#84METHODS OF TREATING EPIDERMOLYSIS BULLOSA WITH CELL-FREE AMNIOTIC FLUID COMPOSITIONS
#85DRUG DELIVERY SYSTEMS COMPRISING A NEUROTROPHIC AGENT, AN APOPTOSIS SIGNALING FRAGMENT INHIBITOR (FAS) OR FAS LIGAND (FASL) INHIBITOR, A TUMOR NECROSIS FACTOR-ALPHA (TNF-ALPHA) OR TNF RECEPTOR INHIBITOR, A MITOCHONDRIAL PEPTIDE, AN OLIGONUCLEOTIDE, A CHEMOKINE INHIBITOR, OR A CYSTEINE-ASPARTIC PROTEASE INHIBITOR
#86Nerve Guidance Conduit Comprising Neural Crest Stem-Like Cells and/or Schwann Cell Precursor-Like Cells and Methods of Making and Using the Same
#87EXTRACELLULAR VESICLE-BASED AGENTS AND METHODS FOR THE TREATMENT OF NEUROPATHIC DISORDERS
#88USE OF GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR (GDNF) FOR THE TREATMENT OF ENTERIC NEUROPATHIES
#89Nerve Xenografts and Related Methods
#90AGENT FOR USE IN TREATMENT OR PREVENTION OF OPHTHALMIC DISORDERS
#91COMPOSITIONS AND METHODS OF INDUCING DIFFERENTIATION OF A HAIR CELL
#92COMPOSITIONS FOR TREATMENT OF ERECTILE DYSFUNCTION, METHODS FOR PREPARING THE SAME AND APPLICATIONS THEREOF
#93BICYCLIC COMPOUNDS AND METHODS FOR THEIR USE IN TREATING PITT HOPKINS SYNDROME
#94FUSION PROTEINS FOR DELIVERY OF GDNF TO THE CNS
#95Method of treatment
#96REGENERATIVE BIOACTIVE SUSPENSION DERIVED FROM FRESHLY DISAGGREGATED TISSUE AND METHODS OF USE IN CLINICAL THERAPIES
#97COMPOSITIONS AND METHODS FOR RECOMBINANT NERVE GROWTH FACTOR
#98METHODS AND COMPOSITIONS FOR INDUCING DIFFERENTIATION OF HUMAN BROWN ADIPOCYTE PROGENITORS
#99COMPOSITIONS FOR TREATMENT OF AZOOSPERMIA, METHODS FOR PREPARING THE SAME AND APPLICATIONS THEREOF
#100FORMULATION AND TREATMENT FOR OPHTHALMIC DISORDERS
#101Patterned Hydrogel Devices and Methods for Neural Regeneration
#102Ciliary Neurotrophic Factor Receptor Ligands and Methods of Using the Same
#103EMPTY POROUS PARTICLES FOR USE IN TREATMENT, PREVENTION AND/OR POSTPONEMENT OF DEGENERATION OF NEURODEGENERATIVE DISEASES, NEURONS AND GLIA
#104THERMORESPONSIVE HYDROGEL CONTAINING POLYMER MICROPARTICLES FOR NONINVASIVE OCULAR BIOLOGIC DELIVERY
#105COMBINATION THERAPIES FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND RELATED DISORDERS
#106TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS USING PKC ACTIVATORS
#107Methods of treating optic nerve diseases using neural progenitor cell growth factors
#108Supraparticle Formulations
#109PAINLESS NGF FOR FRACTURE REPAIR
#110INHIBITION OF LET7I AS A MEANS TO ENHANCE THE PROTECTIVE EFFECT OF PROGESTERONE AGAINST STROKE
#111COMPOSITION AND METHODS OF AN ADVANCED THERAPY FOR NEURODEGENERATIVE DISEASES
#112NERVE GROWTH FACTOR MUTANT
#113NERVE GROWTH FACTOR MUTANT
#114COMPOUNDS AND TREATMENTS THAT ENHANCE ENTERIC NERVOUS SYSTEM FUNCTION
#115BOLAAMPHIPHILIC COMPOUNDS, COMPOSITIONS AND USES THEREOF
#116USE OF ENCAPSULATED CELL THERAPY FOR TREATMENT OF OPHTHALMIC DISORDERS
#117Methods for promoting wound healing and hair growth comprising GDNF administration
#118Adeno-associated virus vectors for treatment of Rett syndrome
#119AURIS FORMULATIONS FOR TREATING OTIC DISEASES AND CONDITIONS
#120Auris formulations for treating otic diseases and conditions
#121Anti-human NGF antibodies and methods using same
#122COMPOSITIONS AND METHODS FOR TREATING FRONTOTEMPORAL DEMENTIA
#123Compositions and methods for modulating neuronal excitability and motor behavior
#124Fusion proteins containing a BDNF and an anti-human transferrin receptor antibody
#125NEUROPROTECTIVE COMPOSITIONS AND USE THEREOF
#126Polyhedrin-based slow release growth factor system for neuroprotection of retinal ganglion cell neurons
#127Anti-TrkB agonist antibodies binding to D1 domain of TrkB
#128CELL COMPOSITIONS AND USES THEREOF
#129Particles for delivery of proteins and peptides
#130DRUG-LOADED TISSUE ADHESIVE FILM AND PREPARATION METHOD THEREFOR
#131Sustained drug release sheet for treating nerve injury
#132GLYPISOME AS AN ENHANCER OF ANGIOGENIC GROWTH FACTOR ACTIVITY
#133Immunoregulatory molecules and uses therefor
#134PAIN RESPONSE MEDIATOR COMPOSITIONS AND METHODS FOR MAKING AND USING SAME
#135METHOD OF EFFECTING NEUROPROTECTION USING SOLUBLE NEUREGULIN ISOFORMS
#136CELL LINES AND THEIR USE IN ENCAPSULATED CELL BIODELIVERY
#137BIO-MIMETIC FORMULATION
#138Method of effecting neuroprotection using soluble neuregulin isoforms
#139Compositions and Methods for Treatment of Cardiovascular Disorders
#140Use of AKT phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same
#141Methods and compositions for inducible expression of neurotrophic factors
#142Use of immune modulators to improve nerve regeneration
#143COATINGS FOR BIOLOGICAL INTERFACE ON IMPLANTS
#144NANOPARTICLES FOR SUSTAINED OPHTHALMIC DRUG DELIVERY AND METHODS OF USE
#145METHODS AND COMPOSITIONS FOR DIAGNOSING, TREATING, AND MONITORING TREATMENT OF SHANK3 DEFICIENCY ASSOCIATED DISORDERS
#146Gene combination capable of high-efficiency expression of recombinant human nerve growth factor
#147Fusion protein including BDNF
#148USE OF CEREBROLYSIN
#149METHOD OF ENHANCING VIRAL-MEDIATED GENE DELIVERY
#150COMPOSITIONS AND METHODS FOR TREATING NERVE INJURY
#151INHIBITOR OF ASTROCYTE TNF ALPHA FOR USE IN THE TREATMENT OF NEUROLOGICAL DISEASES
#152Nerve growth factor fusion protein, preparation method and use thereof
#153Adeno-associated virus virion for gene transfer to nervous system cells
#154Visible light-curable water-soluble chitosan derivative, chitosan hydrogel, and preparation method therefor
#155METHODS OF TREATING NEURODEGENERATIVE DISEASES
#156Delivery method
#157FUSION PROTEINS FOR DELIVERY OF GDNF TO THE CNS
#158Supraparticles
#159Systems and methods for angiogenic treatment in wound healing
#160Methods of promoting corticospinal neuronal outgrowth in neuronal lesions using a pro-regenerative human osteopontin fragment
#161METHODS AND DEVICES FOR PROMOTING NERVE GROWTH AND REGENERATION
#162ADENO-ASSOCIATED VIRUS VIRIONS WITH VARIANT CAPSID AND METHODS OF USE THEREOF
#163Auris formulations for treating otic diseases and conditions
#164Inhibition of LET7I as a means to enhance the protective effect of progesterone against stroke
#165HSV vectors for delivery of NT3 and treatment of CIPN
#166A TRIPLE-EFFECT COCKTAIL PRODUCED BY NEURAL STEM CELLS AS A NOVEL NEUROREPAIR THERAPY FOR CHRONIC STAGE CNS AUTOIMMUNITY
#167Use of encapsulated cell therapy for treatment of ophthalmic disorders
#168TRKB OR TRKC AGONIST COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC CONDITIONS
#169Sucrose acetate isobutyrate-based compositions, methods and uses thereof
#170Stromal derived factor 1 and its use in the prevention and treatment of erectile dysfunction
#171METHODS AND COMPOSITIONS FOR REDUCING CORNEAL ENDOTHELIAL CELL LOSS
#172METHODS FOR DIFFERENTIATING PLURIPOTENT CELLS
#173NEUROTROPHINS FOR USE IN THE TREATMENT OF HEARING LOSS
#174METHODS FOR PROMOTING WOUND HEALING AND HAIR GROWTH
#175BLOOD SERUM FOR USE IN THE TREATMENT OF NEURODEGENERATIVE OPHTHALMOLOGICAL PATHOLOGIES
#176Reloadable hydrogel system comprising an anti-PEG antibody for treating myocardial infarction
#177Neuro-stem cell stimulation and growth enhancement with implantable nanodevice
#178Combination therapies for the treatment of alzheimer's disease and related disorders
#179Genetic Construct
#180Genetic construct
#181Bioconjugation Methods for Targeted in Situ Therapeutic Delivery
#182Synthetic platelets
#183Anti-TrkB agonist antibodies binding to D5 domain of TrkB and methods of promoting neuronal survival in motor neuron injury, stroke or glaucoma
#184Neuro-stem cell stimulation and growth enhancement with implantable nanodevice
#185Neuro-stem cell stimulation and growth enhancement with implantable nanodevice
#186Method of treatment
#187BOLAAMPHIPHILIC COMPOUNDS, COMPOSITIONS AND USES THEREOF
#188NEUROTROPHIN MUTANTS FOR TREATING HEARING LOSS AND OTHER OTIC DISORDERS
#189Method of selecting agents for the treatment of pain using neuronal differentiation
#190Compositions for biological systems and methods for preparing and using the same
#191METHODS TO ENHANCE NERVE REGENERATION UTILIZING NEURAL STEM CELLS AND IL12P40
#192Ciliary neurotrophic factor receptor ligands and methods of using the same
#193UNIVERSAL PLATFORM FOR TARGETING THERAPIES TO TREAT NEUROLOGICAL DISEASES
#194Method of effecting neuroprotection using soluble neuregulin isoforms
#195METHODS FOR PROMOTING WOUND HEALING AND HAIR GROWTH
#196Auris formulations for treating OTIC diseases and conditions
#197COMPOSITION FOR ALLEVIATING OR TREATING PAIN
#198BIO-MIMETIC FORMULATION
#199BOLAAMPHIPHILIC COMPOUNDS, COMPOSITIONS AND USES THEREOF
#200USE OF AKT PHOSPHORYLATION AS A BIOMARKER FOR PROGNOSING NEURODEGENERATIVE DISEASES AND TREATING SAME
#201Genetically modified muscle cells which express neurotrophic factors
#202Compositions Comprising CDNF or MANF for use in the Intranasal Treatment of Central Nervous System Diseases
#203Postpartum cells derived from placental tissue, and methods of making and using the same
#204IRRADIATION TREATMENT OF NEUROLOGICAL SENSATIONS BY PHOTOABLATION
#205Composition for treating chronic pulmonary disease, comprising exosome derived from thrombin-treated stem cell
#206Compositions and methods for modulating neuronal excitability and motor behavior
#207Neuro-stem cell stimulation and growth enhancement with implantable nanodevice
#208METHODS OF TREATING DISEASES ASSOCIATED WITH ILC3 CELLS
#209Encapsulation-free controlled protein release system
#210CELLULARIZED HYDROGELS AND METHODS OF USING THE SAME
#211Polyelectrolyte complexes for delivery of agents to the CNS
#212Nerve growth factor mutant
#213THERMORESPONSIVE HYDROGEL CONTAINING POLYMER MICROPARTICLES FOR NONINVASIVE OCULAR BIOLOGIC DELIVERY
#214Sustained drug release sheet for treating nerve injury
#215Selection Method Of Highly Active Stem Cell For Treatment Of Intraventricular Hemorrhage In Preterm Infant
#216Adhesive cell tissue gels
#217METHOD OF ENHANCING DOPAMINERGIC NEURONAL CELL GROWTH OR SURVIVAL WITH MANF
#218SYSTEM AND METHOD FOR TREATMENT OF HEMORRHAGIC STROKE
#219Synthetic platelets
#220Methods and kits for guiding growth of cells or cell components and uses thereof in tissue repair
#221LIGHT-ACTIVATED ANCHORING OF THERAPEUTIC FACTORS TO TISSUES
#222PROTEIN CONJUGATE USING A FATTY ACID DERIVATIVE AND METHOD FOR PREPARATION THEREOF
#223Genetic construct
#224Soft tissue repair and regeneration using postpartum-derived cells and cell products
#225Mesenchymal stem cells for the treatment of CNS diseases
#226Glial cell line derived neurotrophic factor, obesity, and obesity-related diseases and conditions
#227MODULATION OF AXON DEGENERATION
#228Soluble MANF in pancreatic beta-cell disorders
#229METHODS AND COMPOSITIONS USING AMPK ACTIVATORS FOR PHARMACOLOGICAL PREVENTION OF CHRONIC PAIN
#230TREATMENT OF NERVOUS SYSTEM DISORDERS USING THYROID HORMONE NEUTRAL DOSES OF RXR AGONISTS
#231Neurotherapeutic nanoparticle compositions comprising leukemia inhibitory factor
#232Use of full-length amelogenin for promoting nerve growth or regeneration
#233THERAPEUTIC PROTEIN FORMULATIONS
#234Compositions for biological systems and methods for preparing and using the same
#235Methods for treating heart failure with a TRKB agonist
#236METHODS OF TREATING NEURODEGENERATIVE DISORDERS
#237METHODS AND COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF PARKINSON'S DISEASE
#238COMPOSITIONS AND METHODS FOR RECOMBINANT NERVE GROWTH FACTOR
#239NANOPARTICLES FOR SUSTAINED OPHTHALMIC DRUG DELIVERY AND METHODS OF USE
#240Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity
#241Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity
#242Compositions and methods for treatment of cardiovascular disorders
#243Combination therapies for the treatment of Alzheimer's disease and related disorders
#244Combination therapies for the treatment of Alzheimer's disease and related disorders
#245Combination therapies for the treatment of Alzheimer'S disease and related disorders
#246Cell lines and their use in encapsulated cell biodelivery
#247P75NTR binding protein-Fc fusion protein and methods of treating pain
#248Nerve growth factor composition and powder injection
#249(E)-3-(3,4-dihydroxyphenyl)-N-(prop-2-yn-1-yl)acrylamide for treatment of neurodegenerative diseases
#250Compositions and methods for treatment of cardiovascular disorders
#251ADMINISTRATION OF GROWTH FACTORS FOR THE TREATMENT OF CNS DISORDERS
#252Neurotrophic factor carrier, method for producing the same, and method for regenerating a nerve using the same
#253Compositions and Methods for Treatment of Cardiovascular Disorders
#254Amidated Dopamine Neuron Stimulating Peptide Restoration of Mitochondrial Activity
#255Isolated adipose-derived mesenchymal stem cells treated with angelica extract or butylidenephthalide, and wherein the cells have an increased mitochondrial membrane potential and a decreased level of IL-8, and methods for treating parkinson's disease
#256NERVE GROWTH FACTOR COMPOSITION AND POWDER INJECTION
#257Nerve growth factor composition and powder injection
#258Use of encapsulated cell therapy for treatment of ophthalmic disorders
#259Methods for differentiating pluripotent cells
#260AAV-mediated gene therapy for RPGR X-linked retinal degeneration
#261BOLAAMPHIPHILIC COMPOUNDS, COMPOSITIONS AND USES THEREOF
#262Methods for treating back or neck pain caused by NGF using a therapeutic agent comprising REN-1820, ALE-0540 and capsaicin
#263METHODS AND COMPOSITIONS FOR TREATING GLAUCOMA
#264SHORT AND D-AMINO ACID-CONTAINING POLYPEPTIDES FOR THERAPEUTIC CONJUGATES AND USES THEREOF
#265Method of treating pain using agents that promote neuronal differentiation
#266Implantable medical devices having double walled microspheres
#267SOLVENT/POLYMER SOLUTIONS AS SUSPENSION VEHICLES
#268LOCALLY RELEASED GROWTH FACTORS TO MEDIATE MOTOR RECOVERY AFTER STROKE
#269Therapeutic use of a growth factor, METRNL
#270Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
#271METHOD OF ENHANCING VIRAL-MEDIATED GENE DELIVERY
#272DOPAMINERGIC NEURONAL SURVIVAL-PROMOTING FACTORS AND USES THEREOF
#273METHODS AND COMPOSITIONS FOR TREATING RETINAL DISORDERS
#274Human amniotic fluid preparation having long-term stability
#275Modulation of the VPS10p-Domain Receptor Family for the Treatment of Mental and Behavioural Disorders
#276Postpartum cells derived from placental tissue, and methods of making and using the same
#277Methods to enhance nerve regeneration utilizing neural stem cells and IL12P40
#278Methods for treating traumatic brain injury with amnion-derived cellular cytokine solution (ACCS) or amnion-derived multipotent progenitor (AMP) cells
#279Therapeutic Treatment For Metabolic Syndrome, Type 2 Diabetes, Obesity, Or Prediabetes
#280Composition for mRNA delivery
#281Methods of treating neurodegenerative disorders
#282Targeting peptides for directing adeno-associated viruses (AAVs)
#283Postpartum cells derived from placental tissue, and methods of making and using the same
#284Postpartum cells derived from placental tissue, and methods of making and using the same
#285COMPOSITION OF LIPID-BASED NANOPARTICLES FOR SMALL MOLECULES AND MACROMOLECULES
#286Method for stem cell differentiation in vivo by delivery of morphogenes with mesoporous silica and corresponding pharmaceutical active ingredients
#287Splice variants of GDNF and uses thereof
#288Treatment of hyperalgesia, spontaneous pain, and phantom pain
#289Soft tissue repair and regeneration using postpartum-derived cells and cell products
#290Administration of Angiocidin for the Treatment of Cancer
#291Method for treating chemotherapy-induced male infertility
#292MAGNETIC DIRECTED ALIGNMENT OF STEM CELL SCAFFOLDS FOR REGENERATION
#293Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3A/C4A, immunoglobulins and chemotactic factors
#294Method of administering MANF for the protection of sensory cells
#295Adeno-associated virus virions with variant capsid and methods of use thereof
#296Implantable medical devices having double walled microspheres
#297Method of effecting neuroprotection using soluble Neuregulin isoforms
#298Neurogenic brain-derived neurotrophic factor peptides
#299Method of treating intraocular tissue pathologies with nerve growth factor
#300WOUND HEALING COMPOSITION